COVID-19 IN PATIENTS WITH TYPE II DIABETES MELLITUS
The purpose of this study was to investigate features of the course of COVID-19 infection in patients with type II diabetes. A total of 90 patients with confirmed moderate COVID-19 infection were included in this study. The age of the patients ranged between 60 and 65 years. The patients were divided into three groups: group 1 included 30 patients without comorbid pathology, group 2 included 30 patients with type II diabetes, group 3 included 30 patients with type II diabetes and hypertension. The course of COVID-19 infection in group 1 was similar to that of acute respiratory viral infection. The symptoms were rhinitis, chills, sore throat and loss of sense of smell. The patients in group 2 if compared with patients in group 1 had a more severe course of COVID-19 infection. The most common symptoms were cough and dyspnea, high degree of the affected lung tissue according to MSCT at discharge from the hospital. The patients in group 3 had mild catarrhal symptoms. It was found that the patients with comorbidity, especially with both diseases (hypertension and type II diabetes) had severe systemic inflammatory disorders along with persistent hyperglycemia. Systemic inflammatory disorders included delayed normalization of CRP and coagulopathy with thrombocytopenia and the prolonged PT time. With the development of the inflammatory process, сlaudication is aggravated by hemostasis disturbances and leads to renal failure with an increase in serum creatinine and urea levels.